Purple Biotech (PPBT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PPBT Purple Biotech

Watchlist

2.740
+0.550+25.11%

Close Nov 25 16:00 ET

2.800
+0.060+2.19%

Post 18:45 ET

4.29MMarket Cap0.37P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $33 Price Target
BenzingaNov 15 14:44 ET
Promising Interim Results Propel Purple Biotech's Buy Rating Amid Phase 2 Success and Strategic Advancements
TipRanksNov 15 12:15 ET · Ratings
Purple Biotech's Promising Trials and Financial Update
TipRanksNov 15 07:29 ET
Purple Biotech GAAP EPS of -$0.39
Seeking AlphaNov 15 07:10 ET
Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
SECNov 15 07:08 ET · Announcements
Express News | Purple Biotech Ltd: Qtrly Loss per Ads $4.57
ReutersNov 15 07:03 ET

Comments

Stock_Drift

13 hours ago

Premarket Ticks. 5:38am 11/25

$D-Wave Quantum (QBTS.US)$ $Arqit Quantum (ARQQ.US)$ $Quantum Computing (QUBT.US)$ $NOVONIX (NVX.US)$ $Allot (ALLT.US)$ $Purple Biotech (PPBT.US)$ $Palladyne AI (PDYN.US)$ $KULR Technology (KULR.US)$ $Exicure (XCUR.US)$ $Quantum (QMCO.US)$ $Rigetti Computing (RGTI.US)$ $QMMM Holdings (QMMM.US)$
📊⚡️📊

Stock_Drift

Nov 15 06:06

$Purple Biotech (PPBT.US)$

Trytosaveabit

Nov 4 06:52

Update

$Purple Biotech (PPBT.US)$ Reuters· 1 min ago
Purple Biotech Identifies Potential New Serum Biomarker for Its Lead Oncology Therapeutic Candidate Cm24: Associated With 79% Reduction in Risk of Death!
Phase 2 Study of Cm24 in Pancreatic Cancer Expected Q4 2024 Results

Trytosaveabit

Oct 25 06:50

Update

$Purple Biotech (PPBT.US)$ Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK
Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR
Symposium on Molecular Targets and Cancer Therapeutics

CAPTN-3 demonstrates sustained tumor regression in a triple negative breast cancer in-vivo model; A dose dependent activity and a synergistic effect of the engager arms also seen in non-small cell lung cancer patient-derived explants

Lead tribody IM1240 data demonstrated...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

PPBT Purple Biotech

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target